Key Events This Week
30 Mar: New 52-week low at Rs.422.85 amid broad market weakness
01 Apr: Intraday high of Rs.459.85 with a 7.83% surge
02 Apr: Continued gains, closing at Rs.475.15 (+3.20%)
03 Apr: Week closes at Rs.475.15, up 7.28% for the week
Apr 28
BSE+NSE Vol: 73.21 k

Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics discussed here represent the stock’s current position as of 25 April 2026, providing investors with the latest insights into its performance and prospects.
Read full news article
Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Solara Active Pharma Sciences Ltd has experienced a nuanced shift in its technical momentum, with recent indicators signalling a transition from bearish to mildly bearish territory. Despite a modest 2.81% gain on 9 Apr 2026, the stock’s broader technical landscape remains complex, reflecting mixed signals from key momentum and trend indicators.
Read full news article
30 Mar: New 52-week low at Rs.422.85 amid broad market weakness
01 Apr: Intraday high of Rs.459.85 with a 7.83% surge
02 Apr: Continued gains, closing at Rs.475.15 (+3.20%)
03 Apr: Week closes at Rs.475.15, up 7.28% for the week

Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the stock’s current position as of 03 April 2026, providing investors with the latest comprehensive view.
Read full news article
The Sensex advanced 2.49% on 1 Apr 2026, yet Solara Active Pharma Sciences Ltd outpaced the broader market with a 7.83% gain, reaching an intraday high of Rs 459.85. This 6.23-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.07% rise signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news article
Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleSolara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated December 09, 2019, titled "Appointment of Mr. Bharath R. Sesha Chief Executive Officer.".
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 248000 Equity Shares under ESOP
Solara Active Pharma Sciences Limited has informed the Exchange that Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
No Upcoming Board Meetings
Solara Active Pharma Sciences Ltd has declared 30% dividend, ex-date: 18 Aug 21
No Splits history available
No Bonus history available
Solara Active Pharma Sciences Ltd has announced 1:3 rights issue, ex-date: 15 May 24